These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36826985)

  • 1. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy.
    Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
    JMIR Hum Factors; 2023 Feb; 10():e43529. PubMed ID: 36826985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study.
    Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
    JMIR Form Res; 2023 Sep; 7():e48976. PubMed ID: 37773620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework.
    Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
    Interact J Med Res; 2022 Oct; 11(2):e40597. PubMed ID: 36222800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective.
    Hussain R; Hassali MA; Ur Rehman A; Muneswarao J; Atif M; Babar ZU
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32349339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' experiences on adverse drug reaction: 10 years later.
    Karuppannan M; Mohamad Rizal NAN; Wong KT; Mohd Ali S; Ting KN; Boardman H
    Front Pharmacol; 2022; 13():932942. PubMed ID: 36249772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.
    Cheema E; Haseeb A; Khan TM; Sutcliffe P; Singer DR
    Pharm Pract (Granada); 2017; 15(3):931. PubMed ID: 28943977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.
    Vergeire-Dalmacion G; Castillo-Carandang NT; Juban NR; Amarillo ML; Tagle MP; Baja ES
    JMIR Public Health Surveill; 2015; 1(2):e12. PubMed ID: 27227130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study.
    Kiguba R; Zakumumpa H; Ndagije HB; Mwebaza N; Ssenyonga R; Tregunno P; Harrison K; Pirmohamed M
    Drug Saf; 2023 Jun; 46(6):565-574. PubMed ID: 37097426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
    Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
    Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania.
    Valinciute-Jankauskiene A; Loreta K
    Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33803215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.
    Li R; Curtis K; Van C; Tabish Razi Zaidi S; Yeo CY; Arun Kali C; Zaheen M; Therese Moujalli G; Castelino R
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1165-1175. PubMed ID: 35476123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.